HB 216: RELATING TO PRESCRIPTION DRUGS.
- Session Year: 2025-2026
- House: House
Current Status:
In Progress
(2025-12-08: Carried over to 2026 Regular Session.)
Introduced
First Committee Review
First Chamber
Second Committee Review
Second Chamber
Final Decking
Enacted
Version:
Establishes
requirements for the clinical review criteria and clinical practical guidelines
used to establish step therapy protocols.
Provides a process for a patient to request an exception to using step
therapy protocols. Establishes insurance
coverage requirements relating to the use of step therapy protocols and
standards to appeal an adverse step therapy exception determination.